Log In
Print this Print this

Influenza virus-like particles (VLPs)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionVaccine containing LigoCyte's chimeric virus-like particle technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationInfluenza virus
Indication DetailsPrevent influenza virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today